BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 25092568)

  • 21. Correlation between the renal C1q deposition and serum anti-C1q antibody: a potential role of anti-C1q antibody in lupus nephritis.
    Chen PC; Wang CR; Liu MF; Chen FF; Liang CC
    Asian Pac J Allergy Immunol; 2002 Dec; 20(4):223-7. PubMed ID: 12744622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C1q A08 Is a Half-Cryptic Epitope of Anti-C1q A08 Antibodies in Lupus Nephritis and Important for the Activation of Complement Classical Pathway.
    Wu WJ; Tan Y; Liu XL; Yu F; Zhao MH
    Front Immunol; 2020; 11():848. PubMed ID: 32536911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement 1q (C1q) antibodies levels in sera of Egyptian patients with lupus nephritis.
    Elshweikh SA; Elkhouly RM; Shaalan MM; Shorbagy SH
    Egypt J Immunol; 2014; 21(2):49-59. PubMed ID: 25812352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares.
    Matrat A; Veysseyre-Balter C; Trolliet P; Villar E; Dijoud F; Bienvenu J; Fabien N
    Lupus; 2011 Jan; 20(1):28-34. PubMed ID: 20943718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C1q and systemic lupus erythematosus.
    Walport MJ; Davies KA; Botto M
    Immunobiology; 1998 Aug; 199(2):265-85. PubMed ID: 9777411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies against C1q in patients with systemic lupus erythematosus.
    Trendelenburg M
    Springer Semin Immunopathol; 2005 Nov; 27(3):276-85. PubMed ID: 16189648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between serum anti-C1q antibody levels and renal pathological characteristics and prognostic significance of anti-C1q antibody in lupus nephritis.
    Cai X; Yang X; Lian F; Lin X; Liang M; Li J; Chen X; Liang L; Qin S; Fu J
    J Rheumatol; 2010 Apr; 37(4):759-65. PubMed ID: 20194446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis.
    Bigler C; Hopfer H; Danner D; Schaller M; Mihatsch MJ; Trendelenburg M
    Nephrol Dial Transplant; 2011 Apr; 26(4):1220-8. PubMed ID: 20841491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-C1q autoantibodies in lupus nephritis.
    Sinico RA; Rimoldi L; Radice A; Bianchi L; Gallelli B; Moroni G
    Ann N Y Acad Sci; 2009 Sep; 1173():47-51. PubMed ID: 19758131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis.
    Yang XW; Tan Y; Yu F; Zhao MH
    Nephrol Dial Transplant; 2012 Sep; 27(9):3552-9. PubMed ID: 22700716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus.
    Gunnarsson I; Rönnelid J; Huang YH; Rogberg S; Nilsson B; Lundberg I; Klareskog L
    Br J Rheumatol; 1997 Jan; 36(1):32-7. PubMed ID: 9117171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-C1q autoantibodies from patients with systemic lupus erythematosus induce C1q production by macrophages.
    Thanei S; Trendelenburg M
    J Leukoc Biol; 2017 Feb; 101(2):481-491. PubMed ID: 27630215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlations of C1q- and C3d-bearing circulating immune complexes with immunopathological disease activity in lupus nephritis patients.
    Muso E; Yashiro M; Ito Y; Yoshida H; Sasayama S
    Nihon Jinzo Gakkai Shi; 1994 Apr; 36(4):345-54. PubMed ID: 8022107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum A08 C1q antibodies are associated with disease activity and prognosis in Chinese patients with lupus nephritis.
    Pang Y; Tan Y; Li Y; Zhang J; Guo Y; Guo Z; Zhang C; Yu F; Zhao MH
    Kidney Int; 2016 Dec; 90(6):1357-1367. PubMed ID: 27745701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
    Holers VM
    J Clin Invest; 2004 Sep; 114(5):616-9. PubMed ID: 15343378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus.
    Seelen MA; Trouw LA; Daha MR
    Curr Opin Nephrol Hypertens; 2003 Nov; 12(6):619-24. PubMed ID: 14564199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C1q as antigen in humoral autoimmune responses.
    Siegert CE; Daha MR
    Immunobiology; 1998 Aug; 199(2):295-302. PubMed ID: 9777413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients.
    Tsacheva I; Radanova M; Todorova N; Argirova T; Kishore U
    Mol Immunol; 2007 Mar; 44(8):2147-51. PubMed ID: 17049989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of anti-C1q antibodies and anti-C1q globular head domain antibodies in sera from Chinese patients with lupus nephritis.
    Tan Y; Zhou W; Yu F; Fang Q; Yang HZ; Zhao MH
    Mol Immunol; 2009 Jul; 46(11-12):2178-82. PubMed ID: 19481805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.